Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 15

1.

PPARgamma agonists rescue increased phosphorylation of FGF14 at S226 in the Tg2576 mouse model of Alzheimer's disease.

Hsu WJ, Wildburger NC, Haidacher SJ, Nenov MN, Folorunso O, Singh AK, Chesson BC, Franklin WF, Cortez I, Sadygov RG, Dineley KT, Rudra JS, Taglialatela G, Lichti CF, Denner L, Laezza F.

Exp Neurol. 2017 Sep;295:1-17. doi: 10.1016/j.expneurol.2017.05.005. Epub 2017 May 15.

PMID:
28522250
2.

The Obesity-Impulsivity Axis: Potential Metabolic Interventions in Chronic Psychiatric Patients.

Sfera A, Osorio C, Inderias LA, Parker V, Price AI, Cummings M.

Front Psychiatry. 2017 Feb 13;8:20. doi: 10.3389/fpsyt.2017.00020. eCollection 2017. Review.

3.

Aripiprazole and Haloperidol Activate GSK3β-Dependent Signalling Pathway Differentially in Various Brain Regions of Rats.

Pan B, Huang XF, Deng C.

Int J Mol Sci. 2016 Mar 28;17(4):459. doi: 10.3390/ijms17040459.

4.

Unique Effects of Acute Aripiprazole Treatment on the Dopamine D2 Receptor Downstream cAMP-PKA and Akt-GSK3β Signalling Pathways in Rats.

Pan B, Chen J, Lian J, Huang XF, Deng C.

PLoS One. 2015 Jul 10;10(7):e0132722. doi: 10.1371/journal.pone.0132722. eCollection 2015.

5.

Cariprazine exerts antimanic properties and interferes with dopamine D2 receptor β-arrestin interactions.

Gao Y, Peterson S, Masri B, Hougland MT, Adham N, Gyertyán I, Kiss B, Caron MG, El-Mallakh RS.

Pharmacol Res Perspect. 2015 Feb;3(1):e00073. doi: 10.1002/prp2.73. Epub 2014 Dec 2.

6.

Decreased store operated Ca2+ entry in dendritic cells isolated from mice expressing PKB/SGK-resistant GSK3.

Schmid E, Yan J, Nurbaeva MK, Russo A, Yang W, Faggio C, Shumilina E, Lang F.

PLoS One. 2014 Feb 11;9(2):e88637. doi: 10.1371/journal.pone.0088637. eCollection 2014.

7.

Comparative study of human and mouse postsynaptic proteomes finds high compositional conservation and abundance differences for key synaptic proteins.

Bayés A, Collins MO, Croning MD, van de Lagemaat LN, Choudhary JS, Grant SG.

PLoS One. 2012;7(10):e46683. doi: 10.1371/journal.pone.0046683. Epub 2012 Oct 5.

8.

Hyperdopaminergic modulation of inhibitory transmission is dependent on GSK-3β signaling-mediated trafficking of GABAA receptors.

Li YC, Wang MJ, Gao WJ.

J Neurochem. 2012 Jul;122(2):308-20. doi: 10.1111/j.1471-4159.2012.07790.x. Epub 2012 Jun 7.

9.

AKT/GSK3 signaling pathway and schizophrenia.

Emamian ES.

Front Mol Neurosci. 2012 Mar 15;5:33. doi: 10.3389/fnmol.2012.00033. eCollection 2012.

10.

GSK-3: Functional Insights from Cell Biology and Animal Models.

Kaidanovich-Beilin O, Woodgett JR.

Front Mol Neurosci. 2011 Nov 16;4:40. doi: 10.3389/fnmol.2011.00040. eCollection 2011.

11.

Group II metabotropic glutamate receptor agonist ameliorates MK801-induced dysfunction of NMDA receptors via the Akt/GSK-3β pathway in adult rat prefrontal cortex.

Xi D, Li YC, Snyder MA, Gao RY, Adelman AE, Zhang W, Shumsky JS, Gao WJ.

Neuropsychopharmacology. 2011 May;36(6):1260-74. doi: 10.1038/npp.2011.12. Epub 2011 Feb 16. Erratum in: Neuropsychopharmacology. 2013 May;38(6):1141.

12.

GSK-3β activity and hyperdopamine-dependent behaviors.

Li YC, Gao WJ.

Neurosci Biobehav Rev. 2011 Jan;35(3):645-54. doi: 10.1016/j.neubiorev.2010.08.001. Epub 2010 Aug 18. Review. Erratum in: Neurosci Biobehav Rev. 2013 Mar;37(3):549.

13.

Genetic and pharmacological evidence for schizophrenia-related Disc1 interaction with GSK-3.

Lipina TV, Kaidanovich-Beilin O, Patel S, Wang M, Clapcote SJ, Liu F, Woodgett JR, Roder JC.

Synapse. 2011 Mar;65(3):234-48. doi: 10.1002/syn.20839.

14.

Activation of glycogen synthase kinase-3 beta is required for hyperdopamine and D2 receptor-mediated inhibition of synaptic NMDA receptor function in the rat prefrontal cortex.

Li YC, Xi D, Roman J, Huang YQ, Gao WJ.

J Neurosci. 2009 Dec 9;29(49):15551-63. doi: 10.1523/JNEUROSCI.3336-09.2009. Erratum in: J Neurosci. 2012 Feb 1;32(5):1914.

15.

Modeling the positive symptoms of schizophrenia in genetically modified mice: pharmacology and methodology aspects.

van den Buuse M.

Schizophr Bull. 2010 Mar;36(2):246-70. doi: 10.1093/schbul/sbp132. Epub 2009 Nov 9. Review.

Supplemental Content

Support Center